Medicare Enrolled
Dr. Gary Alweiss, MD
Neurology · Englewood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alweiss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alweiss?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alweiss
Dr. Gary Alweiss is a neurology specialist in Englewood, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alweiss performed 550 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Alweiss received a total of $11,788 from 69 pharmaceutical and/or device companies across 773 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alweiss is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 550 Medicare services
$11,788 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗550
Medicare services
Bottom 46% in NJ for neurology
Not available
Unique patients (not deduplicated)
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
201 | $77 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
141 | $99 | $240 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
70 | $56 | $210 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
49 | $89 | $315 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $132 | $325 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
23 | $153 | $685 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
20 | $109 | $520 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
20 | $181 | $820 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,788
Total received (2018-2024)
Avg $1,684/year across 7 years
Top 22% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
773
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,211
2023
$2,518
2022
$2,024
2021
$1,307
2020
$1,439
2019
$1,030
2018
$1,258
Payments by company (2024)
Teva Pharmaceuticals USA, Inc.
$412
Eisai Inc.
$198
Lilly USA, LLC
$197
ARGENX US, INC.
$180
Novartis Pharmaceuticals Corporation
$175
PFIZER INC.
$157
ABBVIE INC.
$153
GENZYME CORPORATION
$140
EMD Serono, Inc.
$85
Kyowa Kirin, Inc.
$78
Otsuka America Pharmaceutical, Inc.
$68
CSL Behring
$37
Lundbeck LLC
$35
Celgene Corporation
$34
Neurelis, Inc.
$30
Ipsen Biopharmaceuticals, Inc
$29
ACADIA Pharmaceuticals Inc
$28
Neuronetics, Inc.
$26
GE HEALTHCARE
$20
UCB, Inc.
$20
Azurity Pharmaceuticals, Inc.
$17
Life Molecular Imaging Ltd
$17
SCILEX PHARMACEUTICALS INC.
$17
MDD US Operations, LLC
$17
Alnylam Pharmaceuticals Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Genentech USA, Inc.
$14
Top 3 companies account for 36.5% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$3,373
EMD Serono, Inc.
$728
Novartis Pharmaceuticals Corporation
$476
Lilly USA, LLC
$444
Celgene Corporation
$375
CSL Behring
$368
Biogen, Inc.
$333
ABBVIE INC.
$310
AbbVie Inc.
$305
Allergan, Inc.
$280
Neurocrine Biosciences, Inc.
$252
ACADIA Pharmaceuticals Inc
$251
PFIZER INC.
$249
ARGENX US, INC.
$246
GENZYME CORPORATION
$239
Lundbeck LLC
$226
Abbott Laboratories
$223
Eisai Inc.
$213
Biohaven Pharmaceutical Holding Company Ltd.
$203
Upsher-Smith Laboratories LLC
$199
Alexion Pharmaceuticals, Inc.
$181
Allergan Inc.
$145
Janssen Pharmaceuticals, Inc
$134
Kyowa Kirin, Inc.
$124
MDD US Operations, LLC
$121
SK Life Science, Inc.
$118
AbbVie, Inc.
$109
JAZZ PHARMACEUTICALS INC.
$91
Otsuka America Pharmaceutical, Inc.
$85
Sunovion Pharmaceuticals Inc.
$83
Alnylam Pharmaceuticals Inc.
$73
Genentech USA, Inc.
$69
Acorda Therapeutics, Inc
$69
Adamas Pharmaceuticals, Inc.
$67
Amgen Inc.
$61
E.R. Squibb & Sons, L.L.C.
$60
Supernus Pharmaceuticals, Inc.
$60
Impax Laboratories, Inc.
$57
Bausch Health US, LLC
$53
UCB, Inc.
$48
Grifols USA, LLC
$42
Neurelis, Inc.
$42
Octapharma USA, Inc.
$41
Mallinckrodt LLC
$39
Jazz Pharmaceuticals Inc.
$39
Azurity Pharmaceuticals, Inc.
$34
Penumbra, Inc.
$31
Almatica Pharma LLC
$30
Harmony Biosciences LLC
$30
Ipsen Biopharmaceuticals, Inc
$29
Vertical Pharmaceuticals, LLC
$28
Neuronetics, Inc.
$26
Validus Pharmaceuticals LLC
$25
GE HEALTHCARE
$20
CATALYST PHARMACEUTICALS, INC.
$18
Strongbridge US INC.
$18
Life Molecular Imaging Ltd
$17
SCILEX PHARMACEUTICALS INC.
$17
AQUESTIVE THERAPEUTICS, INC.
$16
Merck Sharp & Dohme LLC
$16
Avion Pharmaceuticals
$16
Scilex Pharmaceuticals Inc.
$15
Aprecia Pharmaceuticals, LLC
$15
AstraZeneca Pharmaceuticals LP
$15
Avanir Pharmaceuticals, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$14
Amneal Pharmaceuticals LLC
$13
W. L. Gore & Associates, Inc.
$13
Mallinckrodt Enterprises LLC
$13
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Artemis · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · DUOPA · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Enspryng · Equetro · FIRDAPSE · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAPRELAN · NEURACEQ · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · Ongentys · PANZYGA · PAXLOVID · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SUNOSI · SYMPAZAN · Soliris · Spritam · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XADAGO · Xyrem · ZEPOSIA · ZTLido · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
1,271
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alweiss is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alweiss experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Alweiss performed 201 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alweiss receive payments from pharmaceutical companies?
Yes. Dr. Alweiss received a total of $11,788 from 69 companies across 773 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alweiss's costs compare to other neurologists in Englewood?
Dr. Alweiss's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alweiss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Englewood
Browse neurologists in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology